Will I need maintenance therapy?

 

Q: Will I need maintenance therapy?

A: Your doctor may advise that you receive on-going medication after your original treatment ends. This is called maintenance therapy. It helps keep certain cancers in remission and supports the continued effectiveness of your original treatment.

Whether you will have maintenance therapy or not depends upon the type of cancer you had and how it was treated. You may receive a long-standing medication or one that is undergoing clinical trials. Talk with your health care team about what type of posttreatment therapy you'll be on, the schedule you'll need to follow, and any possible side effects you should watch for.

Many patients do not receive maintenance therapy after completion of initial treatment. This can be a difficult time emotionally because questions come to your mind such as "If I don't receive any more treatment, will the cancer come back?" Discuss your feelings with your health care team. These are normal feelings and your health care team can help get you through this time of transition.
--Bernice Crook, RN, OCN

Here are some questions to ask about posttreatment care.

Latest Cancer News
ACOG Updates Cervical Cancer Screening Guidelines

November 20, 2009 — The American College of Obstetricians and Gynecologists (ACOG) has revised its cervical cancer screening recommendations: the organization now recommends that women begin screening at the age of 21 and receive screening at less frequent intervals. These recommendations will be published in the December 2009 issue of Obstetrics and Gynecology.

New Velcade®-melphalan Transplant Regimen for Multiple Myeloma

November 20, 2009 — Researchers from France have reported encouraging results with adding Velcade® (bortezomib) to high-dose melphalan followed by autologus stem cell infusion for initial treatment of patients with newly diagnosed multiple myeloma. The details of this Phase II study appeared in an early online publication in Blood on November 2, 2009.

Folic Acid May Be Beneficial in Patients with Recurrent Colorectal Adenoma Who Are Folate Deficient

November 20, 2009 — Researchers affiliated with the Health Professional Follow-Up Study and the Nurses’ Health Study have reported that folic acid supplementation in patients with recurrent colorectal adenoma was not protective or harmful in most patients. However, patients who were folate deficient had a significant 39% decrease in adenoma recurrence. The details of this study appeared in an early online publication on October 28, 2009 in the American Journal of Clinical Nutrition.

Select news items provided by Reuters Health